Skip to main content
. Author manuscript; available in PMC: 2024 Jul 12.
Published in final edited form as: JACC Cardiovasc Imaging. 2021 Aug 18;15(8):1391–1405. doi: 10.1016/j.jcmg.2021.07.010

TABLE 2.

Multivariable Logistic Regression Models of Diagnostic Features by Mass Type

Mass Type OR 95% CI P Value Model C-Statistic
Multivariable models: CMR tissue characteristics
 Fibroma (n = 55/86)a Cine SSFP intensity ratio 0.005 0.98
 High (>1.6) Ref.
 Medium (1.1–1.6) 12 2–72
 Low (<1.1) 26 4–188
Fibroma LGE pattern 29 6–141 <0.001
LGE intensity ratio
 Low (<1.4) Ref. 0.007
 Medium (1.4–4.2) 12 1–94
 High (>4.2) 35 4–317
T2 intensity ratio <0.001
 High (>1.7) Ref.
 Medium (1.1–1.7) 60 7–531
 Low (<1.7) 37 5–270
 Rhabdomyoma (n = 22/143)a Cine SSFP intensity ratio 0.005 0.93
 High (>1.6) Ref.
 Medium (1.1–1.6) 9 2–43
 Low (<1.1) 9 2–39
LGE intensity ratio <0.001
 High (>4.2) Ref.
 Medium (1.4–4.2) 3 0.1–74
 Low (<1.4) 113 7-NE
 Malignant (n = 24/146)a T2 intensity ratio 0.003 0.69
 Low (<1.7) Ref.
 Medium (1.1–1.7) 2 0.5–8
 High (>1.7) 5 2–19
 Myxoma (n = 15/196)a Cine SSFP intensity ratio <0.001 0.83
 Low (<1.1) Ref.
 Medium (1.1–1.6) 3 0.1–80
 High (>1.6) 34 2–600
 Teratoma (n = 9/204)a Cine SSFP intensity ratio <0.001 0.80
 Low (<1.1) Ref.
 Medium (1.1–1.6) 0.3 0.01–9
 High (>1.6) 6 1.01–36
 Hemangioma (n = 6/145)a FPP intensity ratio ≥1 152 8-NE <0.001 0.96
Multivariable models: all variables
 Fibroma (n = 59/106)a Cine SSFP intensity ratio 0.004 0.99
 High (>1.6) Ref.
 Medium (1.1–1.6) 6 0.8–37
 Low (<1.1) 36 4–302
Fibroma LGE pattern 9 2–43 0.004
LGE intensity ratio 0.010
 Low (<1.4) Ref.
 Medium (1.4–4.2) 30 2–421
 High (>4.2) 79 5-NE
Mass-to-cardiac length ratio >0.6 23 3–205 0.005
Intramyocardial 94 10–858 <0.001
 Rhabdomyoma (n = 22/143)a Cine SSFP intensity ratio 0.012 0.97
 High (>1.6) Ref.
 Medium (1.1–1.6) 12 2–66
 Low (<1.1) 12 2–81
LGE intensity ratio <0.001
 High (>4.2) Ref.
 Medium (1.4–4.2) 2 0.1–52
 Low (<1.4) 188 10-NE
Age, y 0.008
 High (>7) Ref.
 Medium (0.7–7) 30 1–610
 Low (<0.7) 122 5-NE
 Malignant (n = 24/146)a History of malignancy 71 12–411 <0.001 0.94
Infiltrative 37 10–137 <0.001
Chest pain 8 2–42 0.011
 Myxoma (n = 15/196)a Endocardial 138 8-NE <0.001 0.91
 Teratoma (n = 9/204)a Intrapericardial 606 22-NE <0.001 0.97
Age, y 0.020
 High (>7) Ref.
 Medium (0.7–7) 4 0.1–134
 Low (<0.7) 253 4-NE
 Hemangioma (n = 6/145)a FPP intensity ratio ≥1 152 8-NE <0.001 0.96

Each mass type has 2 separate multivariable logistic regressions with Firth adjustment for sparse data: 1) using 6 CMR tissue characterization sequences (see the “CMR Tissue Characteristics” section); and 2) using all clinical and CMR variables (see the “All Variables” section).

a

The numerator represents the group whose characteristics are being examined, and the denominator represents the comparison group comprising all other tumors; numbers vary based on the number of studies with relevant tissue characterization sequences.

FPP = first pass perfusion; LGE = late gadolinium enhancement; NE = not estimable; OR = odds ratio; Ref. = reference; SSFP = steady-state free precession; other abbreviation as in Table 1.